Bencherif Merouane
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Bencherif Merouane. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| GYRE | SVP, Preclinical Research | Option Exercise | 15,938 | $2.93 | $46,698 | May 18, 2012 |
| GYRE | SVP, Preclinical Research | Option Exercise | 7,951 | $5.55 | $44,128 | Jan 18, 2011 |
| GYRE | SVP, Preclinical Research | Option Exercise | 7,194 | $5.55 | $39,927 | Dec 10, 2010 |
| GYRE | VP, Preclinical Research | Option Exercise | 19,926 | $5.55 | $110,589 | Jan 15, 2010 |
| GYRE | VP, Preclinical Research | Sale | 7,735 | $20.81 | $160,965 | Jan 4, 2010 |
| GYRE | VP, Preclinical Research | Option Exercise | 15,532 | $8.51 | $132,177 | Dec 16, 2009 |
| GYRE | VP, Preclinical Research | Option Exercise | 4,967 | $8.51 | $42,269 | Dec 14, 2009 |
| GYRE | VP, Preclinical Research | Sale | 41,213 | $10.39 | $428,203 | Jul 28, 2009 |
| GYRE | VP, Preclinical Research | Option Exercise | 5,314 | $5.10 | $27,101 | Jul 27, 2009 |